Tablet
ABIRATERONE TEVA TABLETS 500MG
Summary
ABIRATERONE TEVA TABLETS 500MG — Tablet containing abiraterone acetate. Hong Kong Registration No. HK-67917. Certificate Holder: TEVA PHARMACEUTICAL HONG KONG O/B TEVA PHARMACEUTICAL HONG KONG LIMITED. Date of Registration: 28 Jul, 2023.
Product NameABIRATERONE TEVA TABLETS 500MG
Registration No.HK-67917
Certificate HolderTEVA PHARMACEUTICAL HONG KONG O/B TEVA PHARMACEUTICAL HONG KONG LIMITED
Holder AddressFLAT/RM 2303, 23/F, MIRA PLACE TOWER A, 132 NATHAN ROAD, TSIM SHA TSUI, KOWLOON
Ingredientsabiraterone acetate
Dosage FormTablet
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration28 Jul, 2023
ATC codesL02BX03
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents
All ATC groupsL02
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。